MoneyWorks4Me

Amrutanjan Health Care Ltd (AMRUTANJAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590006 NSE: AMRUTANJAN Pharmaceuticals & Drugs | Small Cap | Amrutanjan Health. Share Price

₹490.35 -3.45 (-0.70%)

As on 11-Sep'26 16:59

Amrutanjan Health Care Ltd (AMRUTANJAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590006 NSE: AMRUTANJAN Pharmaceuticals & Drugs | Small Cap | Amrutanjan Health. Share Price

₹490.35 -3.45 (-0.70%)

As on 11-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹1,418 Cr.
Current Price
₹490.4
52-Week Low / High
₹483 / 785
TTM EPS
₹18.7
TTM Sales
₹511 Cr.
Book Value per Share
₹129.8
P/E Ratio
26.27
Lower than its 5-year historical median
Industry PE
54.2
Price to Book (P/B)
3.78
Lower than its 5-year historical median
Price to Sales (P/S)
2.77
Lower than its 5-year historical median
EV/EBITDA
15.31
Lower than its 5-year historical median
Dividend Yield
1%
Profitability Efficiency
Return on Equity (ROE)
16.62%
Outperforms industry median
Return on Capital Employed (ROCE)
22.46%
Outperforms industry median
Return on Assets (ROA)
12.57%
Operating Profit Margin
15.1%
Net Profit Margin
11.52%
Gross Profit Margin
18.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
11.23%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
30.1%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
13.95%
Asset Quality
Promoter Holding
46.52%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹372 Cr.
Equity
₹2.9 Cr.
Face Value
₹1
All Time Low / High
₹5.05 / 1025.55

Amrutanjan Health Care stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Undervalued

Price Trend

Weak
Q.1 Is Amrutanjan Health Care Ltd a good quality company?
Amrutanjan Health Care Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Amrutanjan Health Care Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Amrutanjan Health Care Ltd vs industry peers?
Amrutanjan Health Care Ltd revenue CAGR is 8.59%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Amrutanjan Health Care Ltd?
Promoters hold 46.52% of the Amrutanjan Health Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Amrutanjan Health Care Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 8.5% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amrutanjan Health Care Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 28.7%27%25.4%22.8%44%37.9%19.4%21.5%22.6%22.5%-
Value Creation
Index
1.10.90.80.62.11.70.40.50.60.6-

Growth Parameters

Sales 212220253261333406380421452503511
Sales YoY Gr.-4%15.2%3.2%27.3%21.9%-6.5%11%7.3%11.2%-
Adj EPS 7.56.48.48.620.92313.615.517.622.218.7
YoY Gr.--14.9%31.4%2%144.9%9.8%-40.8%14.1%13.2%26.2%-
BVPS (₹) 39.64449.954.573.590.599.199.9112.8128.3129.8
Adj Net
Profit
21.918.724.52561.267.239.844.950.864.254
Cash Flow from Ops. 8.319.121.218.290.952.220.227.950.936-
Debt/CF from Ops. 0.3000000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 10.1%8.6%9.8%11.2%
Adj EPS 12.8%1.2%17.7%26.2%
BVPS14%11.8%9%13.7%
Share Price 8.5% -7.7% -8.7% -35.6%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
18.615.317.916.432.72814.315.516.518.414.5
Op. Profit
Mgn %
14.212.912.211.820.319.111.812.412.915.114.4
Net Profit
Mgn %
10.48.59.79.618.416.610.510.711.312.810.6
Debt to
Equity
0000000000-
Working Cap
Days
12211181125115130208224224210100
Cash Conv.
Cycle
24121419-7-12065466

Valuation of Amrutanjan Health. - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales212220253261333406380421452503
Operating Expenses + 182192222231266328335369394427
Manufacturing Costs7171617182934353536
Material Costs8796119117140180182212223244
Employee Cost 30343339424849485964
Other Costs 57455457667171757683
Operating Profit 30283131677845525876
Operating Profit Margin (%) 14.1%12.9%12.2%11.8%20.2%19.1%11.7%12.3%12.9%15.1%
Other Income + 7878191715161818
Exceptional Items 000000000-9
Interest 1000110000
Depreciation 3334445676
Profit Before Tax 34333534829154626978
Tax 1213109212314171820
Profit After Tax 22202525616740455158
PAT Margin (%) 10.3%9.1%9.7%9.6%18.4%16.6%10.5%10.7%11.3%11.5%
Adjusted EPS (₹)7.56.98.48.620.923.013.615.617.620.0
Dividend Payout Ratio (%)25.80%28.40%25.60%24.50%20.10%20%33.80%29.60%26.20%24.50%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 116129146159215265290289326371
Share Capital 3333333333
Reserves 113126143157212262287286323368
Debt +2000000000
Long Term Debt0000000000
Short Term Debt2000000000
Minority Interest0000000000
Trade Payables25263031416047566971
Others Liabilities 57810152121192362
Total Liabilities 149162183201271346358364418504

Fixed Assets

Net Fixed Assets +27282626232849504951
Gross Block30333539394874768289
Accumulated Depreciation36913161925263238
CWIP 10002171216106
Investments 108181818135003
Inventories10101524172629292737
Trade Receivables29283326183833485661
Cash Equivalents 317381361398870278333
Others Assets 4216117054136170208186212
Total Assets 149162183201271346358364418504
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + 8192118915220285136
PBT 34333534829154626978
Adjustment -0-4-3-1-3-10-8-7-9-11
Changes in Working Capital -110-1-431-4-10-109-12
Tax Paid -14-11-10-11-19-24-16-16-18-19
Cash Flow From Investing Activity + -0-8-11-14-88-36-219-31-21
Capex -4-1-2-3-2-23-9-6-36-55
Net Investments -1-13-14-17-92-25-512-1118
Others 465661311141616
Cash Flow From Financing Activity + -5-9-7-12-7-17-15-48-13-14
Net Proceeds from Shares 0000000100
Net Proceeds from Borrowing 0000000000
Interest Paid -1-0-0-0-000000
Dividend Paid -4-6-6-9-6-12-14-13-13-13
Others -0-4-1-2-2-4-1-36-0-0
Net Cash Flow 323-7-4-13-161
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)18.4616.4117.8716.4432.6928.0314.3715.5416.5316.62
ROCE (%)28.6526.9525.4322.84437.9319.3821.4722.5822.46
Asset Turnover Ratio1.491.421.471.361.411.321.081.171.161.09
PAT to CFO Conversion(x)0.360.950.840.721.490.780.50.6210.62
Working Capital Days
Receivable Days45.1046.7043.9041.5024.2025.2034.3035.1041.9042.30
Inventory Days14.8016.801826.7022.6019.5026.402522.7023.50
Payable Days71.6098.1086.4095.4093.80102.30108.2089102.10104.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amrutanjan Health Care Ltd FAQs

The current trading price of Amrutanjan Health. on 11-Sep-2026 16:59 is ₹490.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Amrutanjan Health. stood at ₹1,417.6 Cr

The latest P/E ratio of Amrutanjan Health. as of 10-Sep-2026 is 26.27.

The latest P/B ratio of Amrutanjan Health. as of 10-Sep-2026 is 3.78.

The 52-week high of Amrutanjan Health. is ₹784.8 and the 52-week low is ₹482.6.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amrutanjan Health. is ₹511 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amrutanjan Health Care Ltd is a good quality company.

The key valuation ratios of Amrutanjan Health Care Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Amrutanjan Health Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Amrutanjan Health Care Ltd

Amrutanjan Health Care was started in the year 1893 by social reformer, journalist and freedom fighter, Nageswara Rao Pantulu Garu. Today Amrutanjan is one of the household names in South India.

While Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company with a rich heritage of over 100 years, the company is also planning to introduce a series of next generation products in healthcare category.

With a wide range of ayurvedic and allopathic products, Amrutanjan has helped millions of people relieve themselves from the pain and discomfort of headaches, colds, sprains, muscular pains, rheumatic pains and stands a real pain management specialist for its loyal customers.

The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai.  Apart from the products in the pain care segment, other categories include cough and cold care, health and home care.

Its products are available in the Gulf, African, South East and Asian countries. Plans are ready to enter the US and European markets in a big way.

Products

  • Amrutanjan pain balm
  • Dragon Roll-on liquid balm
  • Joint ache cream
  • Pain relief kit
  • Cold rub
  • Vaporising gel
  • Cough drops
  • Swas mint
  • Diakyur capsules
  • Jiffy tablets
  • Decorn (corn caps)
  • Cutis olive oil, etc.
You have 43 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now